Our Focus on Immuno-Oncology

In the field of immuno-oncology, the STAM™ mouse is the most pathologically suitable model for developing new therapeutic drugs for liver cancer.

The utilization of STAM™ mouse enables non-clinical research for the development of liver cancer therapeutics targeting immune cells, tumor microenvironment, and genetic mutations.

READ MORE

NEWS RELEASE

Devonian Reports Positive Results in MASH Liver Study

In a great collaboration with Devonian Health Group Inc., we are happy to demonstrate preclinical proof of con…

READ MORE

EVENT

SMC will be exhibiting at The 110th General Meeting of the Japanese Society of Gastroenterology

We are pleased to announce that SMC Laboratories will be exhibiting at The 110th General Meeting of the Japane…

READ MORE

Sci Rep.,

“Periodontitis promotes hepatocellular carcinoma in Stelic Animal model (STAM) mice” (Sci. Rep., DOI: 10.1038/s41598-024-68422-7, 2024)

READ MORE

STAM™ model

Our STAM™ model is a model that recapitulates the same disease progression as human MASH/HCC.

READ MORE

SERVICE

Search by topics

COLUMN

2025.03.21

SMC’s IPF study experience

Today, we would like to introduce our experience of the bleomycin-induced IPF study.   One of our most re…

READ MORE

2025.03.14

Advanced Non-Clinical COPD Model Mouse for Your Drug Development Needs

In this article, we introduce our COPD model.   Why Choose Our COPD Model? ✅Clinically Relevant Evaluatio…

READ MORE

2025.03.07

Get the Latest CCl4 Model Material

We are pleased to share with you the latest material introducing our CCl4 model, which should provide valuable…

READ MORE

2025.02.27

Get The Latest Materials on Lung Disease Models

We are pleased to introduce the latest materials showcasing our lung disease models, designed to provide valua…

READ MORE

2025.02.21

Get the Latest BDL Model Material

We are pleased to share with you the latest material introducing our BDL model, which should provide valuable …

READ MORE

2025.02.14

Get Latest UUO Model Material

We are pleased to share the latest material introducing our UUO model, which should provide valuable insights …

READ MORE

Bleomycin-induced pulmonary fibrosis model

DISEASE AREAIPFTHERAPEUTIC AREAS

LEARN MORE

Porcine Pancreatic Elastase (PPE) model

COPDDISEASE AREATHERAPEUTIC AREAS

LEARN MORE

CCl4-induced liver fibrosis model

CirrhosisDISEASE AREATHERAPEUTIC AREAS

LEARN MORE

Bile duct ligation (BDL) model

DISEASE AREAPBCTHERAPEUTIC AREAS

LEARN MORE

TAA-induced acute liver failure model

ALFDISEASE AREATHERAPEUTIC AREAS

LEARN MORE

New stage

Our service and disease mouse models bridge the development of the next- Generation Cancer Therapies in the field of Immuno-oncology.

LEARN MORE

New stage

SMC Laboratories,Inc.

COMPANY

At SMC Laboratories, we support drug research with our cutting-edge non-clinical pharmacology studies to quickly deliver therapeutic drugs to patients suffering from diseases that cannot be treated with existing drugs.

LEARN MORE

PUBLICATION

We, SMC Laboratories, are highly regarded worldwide as a consulting – based CRO that designs tailored to the needs of pharmaceutical companies and research institutions.

NEWS

2025.03.04

NEWS RELEASE

Devonian Reports Positive Results in MASH Liver Study

In a great collaboration with Devonian Health Group Inc., we are happy to demonstrate preclinical proof of con…

READ MORE

2025.02.28

NEWS RELEASE

CytoDyn Reports Significant Fibrosis Reversal in SMC Lab Studies

In a great collaboration with CytoDyn Inc., we are pleased to share promising preclinical results demonstratin…

READ MORE

2024.12.27

Case study: Study published in Periodontitis promotes hepatocellular carcinoma Stelic Animal model mice.

We introduce a case study of basic research using our MASH model (STAM™ model).   It has been reported th…

READ MORE

2024.12.09

CytoDyn has published a press release regarding the leronlimab efficacy preclinical study for MASH/fibrosis provided by SMC

CytoDyn Inc., which is our client, has announced the results of pharmacology study using a STAM™ mouse model. …

READ MORE

2024.11.28

Case study: Study published in Clinical and Translational Science on the effects of adiponectin-derived peptide ALY688 in MASH/liver fibrosis of STAM model.

We introduce a case study of pharmacology study of adiponectin-derived peptide ALY688 using our MASH model (ST…

READ MORE

2024.11.15

PUBLICATION

Our clients’ presentations at AASLD ~The Liver Meeting 2024 ~

Our clients presented data on treatment of MASH using STAMTM model at the AASLD ~The Liver Metting 2024~ (Nove…

READ MORE